CapsoVision, Inc reported the full year ended December 31, 2025 results: revenue $13.6 million.
“Full year 2025 revenue was $13.6 million, a 15% increase compared to full year 2024.”
CapsoVision, Inc — fact timeline
Source-grounded facts extracted from CapsoVision, Inc's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
CapsoVision, Inc reported the fourth quarter ended December 31, 2025 results: revenue $3.9 million.
“Fourth quarter 2025 revenue was $3.9 million, a 13% increase over the fourth quarter of 2024.”
CapsoVision, Inc entered into Registration Rights Agreement with the Investors (effective 2026-03-16).
“In connection with the Private Placement, the Company entered into a registration rights agreement, dated March 16, 2026 (the “Registration Rights Agreement”), with the Investors, pursuant to which, among other things, the Company will (i) prepare and file with the Securities and Exchange Commission (the “SEC”) a registration statement to register for resale the Shares within 90 days after the closing of the Private Placement, and (ii) use commercially reasonable efforts to have such registration statement declared effective as soon as reasonably practicable following the filing thereof with the SEC.”
CapsoVision, Inc entered into Securities Purchase Agreement with selected accredited investors (the "Investors") valued at approximately $14 million (effective 2026-03-16).
“On March 16, 2026, CapsoVision, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with selected accredited investors (the “Investors”), for the purposes of raising approximately $14 million in aggregate gross proceeds for the Company (the “Private Placement”).”
CapsoVision, Inc amended Amendment with Canon, Inc, a Japanese corporation valued at $1 million (effective 2026-03-09).
“On March 9, 2026, the Company entered into the amendment to the original development agreement (the “ Amendment”) with Canon, Inc, a Japanese corporation pursuan t to which the Company agreed that the total fee shall be increased by the amount of $1 million due to the increased features in the specification.”
CapsoVision, Inc: Amended and restated bylaws became effective July 3, 2025 in connection with IPO closing (effective 2025-07-03).
“On July 3, 2025, the Company filed its amended and restated certificate of incorporation (the “ Certificate of Incorporation ”) with the Secretary of State of the State of Delaware and its amended and restated bylaws (the “ Bylaws ”) became effective in connection with the closing of the Public Offering.”
CapsoVision, Inc: Amended and restated certificate of incorporation filed with Delaware Secretary of State effective July 3, 2025 in connection with IPO closing (effective 2025-07-03).
“On July 3, 2025, the Company filed its amended and restated certificate of incorporation (the “ Certificate of Incorporation ”) with the Secretary of State of the State of Delaware and its amended and restated bylaws (the “ Bylaws ”) became effective in connection with the closing of the Public Offering.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.